Best Potential Tech and AI Stocks

Results

28

4 new

Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.

28 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$544.51-1.6%82.5%US$12.6bUS$679.6411.159.7%n/aPharmaceuticals & Biotech
LITE
US$762.994.1%630.0%US$59.4bUS$1,104.89135.256.5%n/aTech
TVTX
US$57.361.1%274.4%US$5.3bUS$58.719.949.4%n/aPharmaceuticals & Biotech
AV1
AU$0.074-6.3%-43.1%AU$68.6mAU$0.177.2108.4%n/aSoftware
SNDX
US$20.81-8.7%116.1%US$1.8bUS$39.458.568.1%n/aPharmaceuticals & Biotech
APLD
New
US$27.195.4%152.9%US$7.8bUS$73.0524.335.0%n/aSoftware
APP
US$391.98-7.7%7.6%US$131.7bUS$654.6033.621.7%n/aSoftware
FN
New
US$476.04-0.5%54.1%US$17.1bUS$732.4440.522.3%n/aTech
ELS
AU$5.94-10.8%209.4%AU$1.3bAU$9.63122.951.0%n/aTech
SMCI
New
US$30.1024.5%-44.7%US$19.5bUS$37.8115.624.3%n/aTech
ARDX
US$5.03-3.3%17.2%US$1.2bUS$16.302.956.0%n/aPharmaceuticals & Biotech
ANAB
US$54.15-6.6%101.0%US$1.6bUS$87.096.948.1%41.6%Pharmaceuticals & Biotech
MRKR
US$1.22-6.9%-21.8%US$20.3mUS$7.875.769.0%n/aPharmaceuticals & Biotech
KRYS
US$335.19-5.5%127.1%US$9.9bUS$376.7543.935.8%n/aPharmaceuticals & Biotech
CLNN
US$5.39-9.0%47.7%US$68.9mUS$32.20514.064.7%n/aPharmaceuticals & Biotech
IONS
New
US$56.554.0%33.9%US$9.3bUS$91.658.860.0%n/aPharmaceuticals & Biotech
ORCL
US$114.99-9.0%-53.1%US$331.2bUS$248.1519.524.2%1.7%Software
STX
US$851.698.1%464.4%US$192.7bUS$1,008.6181.037.7%0.3%Tech
SNDK
US$1,436.566.0%3,281.7%US$212.7bUS$2,217.7747.246.5%n/aTech
CLS
CA$430.072.0%84.4%CA$49.4bCA$654.2336.627.9%n/aTech
IREN
US$37.0710.3%109.2%US$13.2bUS$81.4083.841.2%n/aSoftware
WRK
AU$0.080%-27.3%AU$158.4mAU$0.1615.7112.0%n/aSoftware
PLTR
US$122.92-7.1%-22.6%US$294.7bUS$182.20129.231.9%n/aSoftware
NET
US$262.15-5.6%32.1%US$93.0bUS$262.2640.039.6%n/aSoftware
Page 1 of 1